Ticker: COGT

Cogent Biosciences, Inc. (NASDAQ: COGT) has released its latest financial results for the second quarter ending June 30, 2025, showcasing both challenges and advancements in its ongoing clinical trials and operations. Key Financial Highlights: Net Loss: The company reported a net loss of $73.5 m...